Literature DB >> 2253003

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

J Scheele1, R Stangl, A Altendorf-Hofmann.   

Abstract

From 1960 to 1987, 1209 patients with colorectal liver metastases were recorded, and followed until 1 January 1990. In 242 cases the diagnosis was based on external imaging, whereas 967 patients had operative confirmation and staging of their liver disease. Three groups of patients were analysed: group 1 involved 921 cases, of whom 902 were deemed non-resectable whereas 19 could not be unequivocally classified. Only 21 patients lived for longer than 3 years, seven survived for 4 years, but there were no 5-year survivors. Group 2 comprised 62 highly selected patients who at laparotomy demonstrated resectable metastatic spread confined to the liver, but this was not treated mainly because of a formerly different therapeutic approach. These patients had a significantly longer median survival time (14.2 versus 6.9 months), but also failed to achieve 5-year survival. The 226 patients forming group 3 underwent hepatic resection with intent to cure. Nine of them had minimal macroscopic disease left, and 34 with all gross tumour removed had positive margins. Survival of patients with these 43 eventually non-radical resections followed an identical course as in group 2 (median survival 13.3 months, maximum 42 months). Of the 183 patients with potentially curative resection ten died after surgery (5.5 per cent). Actuarial 5 and 10-year survival rates in the remaining 173 patients were 40 and 27 per cent with 25 and seven patients alive at respective periods of time. Until 1 January 1990, 64 patients remained free from recurrent disease for up to 24 years. In three patients the tumour status at death was unclear. The other 106 patients developed definite cancer relapse. Nevertheless they demonstrated a prolongation of survival time by a median of 1 year when compared with the 43 non-radically resected patients or the 62 untreated patients with resectable liver-only metastases, and accomplished a maximum survival time of 8 years. Radical excision of colorectal secondaries to the liver therefore offers effective palliation, and in a small number the chance of a cure.

Entities:  

Mesh:

Year:  1990        PMID: 2253003     DOI: 10.1002/bjs.1800771115

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  218 in total

1.  Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases.

Authors:  Eduardo de Santibañes; Diego Fernandez; Carlos Vaccaro; Guillermo Ojea Quintana; Fernando Bonadeo; Juan Pekolj; Carlos Bonofiglio; Ernesto Molmenti
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 2.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

3.  Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.

Authors:  Reto Bale; Gerlig Widmann; Peter Schullian; Marion Haidu; Georg Pall; Alexander Klaus; Helmut Weiss; Matthias Biebl; Raimund Margreiter
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

Review 4.  Treatment options for colorectal liver metastases.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

Review 5.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

6.  Indicators for treatment strategies of colorectal liver metastases.

Authors:  H Ueno; H Mochizuki; K Hatsuse; K Hase; T Yamamoto
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

7.  Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.

Authors:  Josep Martí; Josep Fuster; Anna M Solà; Georgina Hotter; Rafael Molina; Amalia Pelegrina; Joana Ferrer; Ramon Deulofeu; Constantino Fondevila; Juan Carlos García-Valdecasas
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

8.  Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma.

Authors:  Atsushi Sasaki; Yukio Iwashita; Kohei Shibata; Toshifumi Matsumoto; Masayuki Ohta; Seigo Kitano
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

9.  Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.

Authors:  Christopher Christophi; Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Vijayaragavan Muralidharan
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

10.  Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.

Authors:  Satoshi Nagayama; Suguru Hasegawa; Koya Hida; Kenji Kawada; Etsuro Hatano; Kojiro Nakamura; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Takashi Matsuo; Masazumi Zaima; Akiyoshi Kanazawa; Hiroaki Terajima; Masaharu Tada; Yukihito Adachi; Ryuta Nishitai; Dai Manaka; Tsunehiro Yoshimura; Koji Doi; Takahiro Horimatsu; Akira Mitsuyoshi; Kenichi Yoshimura; Miyuki Niimi; Shigemi Matsumoto; Yoshiharu Sakai; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2016-10-17       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.